NO2662073T3 - - Google Patents
Info
- Publication number
- NO2662073T3 NO2662073T3 NO13167187A NO13167187A NO2662073T3 NO 2662073 T3 NO2662073 T3 NO 2662073T3 NO 13167187 A NO13167187 A NO 13167187A NO 13167187 A NO13167187 A NO 13167187A NO 2662073 T3 NO2662073 T3 NO 2662073T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1422MU2012 | 2012-05-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2662073T3 true NO2662073T3 (no) | 2018-04-07 |
Family
ID=48288939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO13167187A NO2662073T3 (no) | 2012-05-09 | 2013-05-09 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20130303453A1 (no) |
| EP (1) | EP2662073B1 (no) |
| JP (1) | JP2013234184A (no) |
| DK (1) | DK2662073T3 (no) |
| ES (1) | ES2659166T3 (no) |
| NO (1) | NO2662073T3 (no) |
| PL (1) | PL2662073T3 (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3624829A4 (en) * | 2017-05-15 | 2020-10-28 | Sun Pharmaceutical Industries Limited | OCTREOTIDE INJECTION |
| JP1631348S (no) * | 2017-11-06 | 2019-05-13 | ||
| USD878567S1 (en) * | 2018-07-03 | 2020-03-17 | Haselmeier Ag | Medical injector |
| USD863549S1 (en) * | 2018-07-03 | 2019-10-15 | Haselmeier Ag | Medical injector |
| USD878566S1 (en) * | 2018-07-03 | 2020-03-17 | Haselmeier Ag | Medical injector |
| DK3811927T3 (da) | 2019-10-24 | 2021-12-13 | Sun Pharmaceutical Ind Ltd | Stabil, parenteral doseringsform af cetrorelixacetat |
| US11052196B1 (en) | 2020-11-03 | 2021-07-06 | Sun Pharmaceutical Industries Limited | Method of injecting octreotide acetate into the body |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU641206B2 (en) * | 1991-01-22 | 1993-09-16 | Eli Lilly And Company | Multiple dose injection pen |
| EP2526996B1 (en) * | 2002-12-20 | 2019-09-11 | Xeris Pharmaceuticals, Inc. | Formulation for intracutaneous injection |
| DK1742616T3 (en) * | 2004-04-30 | 2015-01-12 | Abraxis Bioscience Llc | The microsphere-discharge-system for the prolonged delivery and methods of making and using the same |
| JP2007204391A (ja) * | 2006-01-31 | 2007-08-16 | Osaka Medical College | モノクロロ酢酸曝露用初期救急処置セット |
| WO2010115762A1 (en) * | 2009-04-01 | 2010-10-14 | Sanofi-Aventis Deutschland Gmbh | Pen-type drug delivery device with luminous markers |
| CA2790895C (en) * | 2010-02-24 | 2016-08-23 | Jan Jezek | Protein formulations |
-
2013
- 2013-05-08 US US13/889,564 patent/US20130303453A1/en not_active Abandoned
- 2013-05-09 PL PL13167187T patent/PL2662073T3/pl unknown
- 2013-05-09 NO NO13167187A patent/NO2662073T3/no unknown
- 2013-05-09 JP JP2013099173A patent/JP2013234184A/ja active Pending
- 2013-05-09 EP EP13167187.7A patent/EP2662073B1/en active Active
- 2013-05-09 DK DK13167187.7T patent/DK2662073T3/en active
- 2013-05-09 ES ES13167187.7T patent/ES2659166T3/es active Active
-
2014
- 2014-04-01 US US14/242,380 patent/US20140213984A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013234184A (ja) | 2013-11-21 |
| PL2662073T3 (pl) | 2018-04-30 |
| US20140213984A1 (en) | 2014-07-31 |
| EP2662073B1 (en) | 2017-11-08 |
| DK2662073T3 (en) | 2018-02-12 |
| US20130303453A1 (en) | 2013-11-14 |
| EP2662073A1 (en) | 2013-11-13 |
| ES2659166T3 (es) | 2018-03-14 |